{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T05:43:00Z","timestamp":1768110180276,"version":"3.49.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T00:00:00Z","timestamp":1628553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T00:00:00Z","timestamp":1628553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100012581","name":"Macula\u00a0Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012581","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1038\/s41433-021-01735-3","type":"journal-article","created":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T16:07:55Z","timestamp":1628611675000},"page":"1810-1812","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Treatment of Sorsby fundus dystrophy with anti-tumor necrosis factor-alpha medication"],"prefix":"10.1038","volume":"36","author":[{"given":"Richard F.","family":"Spaide","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,10]]},"reference":[{"key":"1735_CR1","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1136\/bjo.33.2.67","volume":"33","author":"A Sorsby","year":"1949","unstructured":"Sorsby A, Mason MEJ. A fundus dystrophy with unusual features. Br J Ophthalmol. 1949;33:67\u201397.","journal-title":"Br J Ophthalmol"},{"key":"1735_CR2","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1016\/S0161-6420(89)32664-9","volume":"96","author":"MRC Capon","year":"1989","unstructured":"Capon MRC, et al. Sorsby\u2019s fundus dystrophy: a light and electron microscopic study. Ophthalmology. 1989;96:1769\u201377.","journal-title":"Ophthalmology"},{"key":"1735_CR3","unstructured":"Duke-Elder S, Perkins ES. Diseases of the uveal tract. System of ophthalmology. London: Kimpton; 1966."},{"key":"1735_CR4","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/ng1294-352","volume":"8","author":"BHF Weber","year":"1994","unstructured":"Weber BHF, Vogt G, Pruett RC, St\u00f6hr H, Felbor U. Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby\u2019s fundus dystrophy. Nat Genet. 1994;8:352\u20136.","journal-title":"Nat Genet"},{"key":"1735_CR5","doi-asserted-by":"publisher","first-page":"4161","DOI":"10.1007\/s00018-021-03779-w","volume":"78","author":"T Kawai","year":"2021","unstructured":"Kawai T, Elliott KJ, Scalia R, Eguchi S. Contribution of ADAM17 and related ADAMs in cardiovascular diseases. Cell Mol Life Sci. 2021;78:4161\u201387.","journal-title":"Cell Mol Life Sci"},{"key":"1735_CR6","doi-asserted-by":"publisher","first-page":"721","DOI":"10.4049\/jimmunol.176.2.721","volume":"176","author":"DS Smookler","year":"2006","unstructured":"Smookler DS, et al. Cutting edge: tissue inhibitor of metalloproteinase 3 regulates TNF-dependent systemic inflammation. J Immunol. 2006;176:721\u20135.","journal-title":"J Immunol"},{"key":"1735_CR7","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrrheum.2015.169","volume":"12","author":"GD Kalliolias","year":"2016","unstructured":"Kalliolias GD, Ivashkiv LB. TNF biology, pathogenic mechanisms and emerging therapeutic strategies. Nat Rev Rheumatol. 2016;12:49\u201362.","journal-title":"Nat Rev Rheumatol"},{"key":"1735_CR8","doi-asserted-by":"publisher","unstructured":"Spaide RF. Long-term visual acuity preservation in Sorsby fundus dystrophy with corticosteroid treatment. Retin Cases Br Rep. 2019. https:\/\/doi.org\/10.1097\/ICB.0000000000000946.","DOI":"10.1097\/ICB.0000000000000946"},{"key":"1735_CR9","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/path.5506","volume":"252","author":"H Hongisto","year":"2020","unstructured":"Hongisto H, et al. In vitro stem cell modelling demonstrates a proof-of-concept for excess functional mutant TIMP3 as the cause of Sorsby fundus dystrophy. J Pathol. 2020;252:138\u201350.","journal-title":"J Pathol"},{"key":"1735_CR10","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nm846","volume":"9","author":"JH Qi","year":"2003","unstructured":"Qi JH, et al. A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nat Med. 2003;9:407\u201315.","journal-title":"Nat Med"},{"key":"1735_CR11","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1038\/ng1413","volume":"36","author":"FF Mohammed","year":"2004","unstructured":"Mohammed FF, et al. Abnormal TNF activity in Timp3\u2212\/\u2212 mice leads to chronic hepatic inflammation and failure of liver regeneration. Nat Genet. 2004;36:969\u201377.","journal-title":"Nat Genet"},{"key":"1735_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep32544","volume":"6","author":"I Meunier","year":"2016","unstructured":"Meunier I, et al. A new autosomal dominant eye and lung syndrome linked to mutations in TIMP3 gene. Sci Rep. 2016;6:1\u20139.","journal-title":"Sci Rep"},{"key":"1735_CR13","first-page":"2292","volume":"14","author":"E An","year":"2008","unstructured":"An E, Gordish-Dressman H, Hathout Y. Effect of TNF-alpha on human ARPE-19-secreted proteins. Mol Vis. 2008;14:2292\u2013303.","journal-title":"Mol Vis"},{"key":"1735_CR14","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.2147\/DDDT.S206355","volume":"13","author":"J Wu","year":"2019","unstructured":"Wu J, Sun X. Complement system and age-related macular degeneration: drugs and challenges. Drug Des Dev Ther. 2019;13:2413\u201325.","journal-title":"Drug Des Dev Ther"},{"key":"1735_CR15","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/S1350-9462(01)00010-6","volume":"20","author":"GS Hageman","year":"2001","unstructured":"Hageman GS, et al. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch\u2019s membrane interface in aging and age-related macular degeneration. Prog Retinal Eye Res. 2001;20:705\u201332.","journal-title":"Prog Retinal Eye Res"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-021-01735-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-021-01735-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-021-01735-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T07:03:49Z","timestamp":1660892629000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-021-01735-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,10]]},"references-count":15,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["1735"],"URL":"https:\/\/doi.org\/10.1038\/s41433-021-01735-3","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,10]]},"assertion":[{"value":"14 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}